November 20, 2015

Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending.

November 19, 2015

The healthcare logistics industry has seen significant improvements in product security and regulatory compliance across the supply chain. 

November 18, 2015

AxelaCare enhances OptumRx’s ability to deliver care to the growing number of consumers managing complex conditions through at-home infusions.

November 17, 2015

Tagrisso is an EGFR-tyrosine kinase inhibitor, a targeted cancer therapy, designed to inhibit both the activating, sensitizing mutations, and T790M, the genetic mutation responsible for EGFR-TKI treatment resistance in up to approximately two-thirds of cases of EGFRm advanced NSCLC. 

November 13, 2015
The drug was granted Fast Track, Breakthrough, Priority Review and Accelerated Approval status by the FDA and has shown an objective response rate of 59% with a median duration of about 12.4 months. 
November 12, 2015

The moves are part of a strategic move to align efforts for internal improvement, the specialty pharmacy operator said. 

November 11, 2015

The combination of Cotellic with Zelboraf helps patients with previously untreated BRAF V600 mutation-positive advanced melanoma live a median of one year (12.3 months) without their disease worsening, compared to 7.2 months with Zelboraf alone.

November 11, 2015

A new drug has been approved that, in conjunction with vemurafenib, is meant to treat metastatic melanoma that can't be removed through surgery with a certain gene mutation. 

November 11, 2015

Consider this: 1-in-5 hospital patients end up back in the hospital within 30 days of their discharge. And the biggest factors pulling them back all have to do with medications — either through medication errors, nonadherence or adverse drug events.

November 6, 2015

Novira is a company working on curative treatments for chronic hepatitis B. 

November 4, 2015

For the full-year 2015, Diplomat Pharmacy now expects revenue between $3.25 and $3.4 billion, up from a previous range of $3.2 to $3.4 billion.

November 4, 2015

Genoa said that the acquisition was part of its strategy to improve patient care at the community mental health centers it partners with amid a shortage of psychiatry providers. The acquisition marks the launch of Genoa Telepsychiatry. 

October 29, 2015

Forbes is reporting that CVS and Express Scripts have cut ties with Valeant Pharmaceuticals’ specialty pharmacy Philidor Rx amid investigations into the company’s business practices. “In accordance with CVS/caremark’s standard auditing protocols, over the last several weeks we have been monitoring and reviewing the results of recent audits of Philidor’s practices,” CVS said in a statement. ”Based on the findings from those activities, we have terminated Philidor for noncompliance with the terms of its provider agreement.” (Forbes)

October 29, 2015

McKesson's North America pharmaceutical distribution and services revenues were $40.6 billion for the quarter, up 16% on a reported basis and 17% on a constant currency basis. 

October 28, 2015

Amgen announced Wednesday that it had received approval from the Food and Drug Administration for Imlygic (talimogene laherparepvec) for injection.

October 26, 2015

Diplomat Pharmacy released a series of videos developed over the past year, each taken to tell the personal stories in specialty pharmacy.

October 26, 2015

The drug is the first to be approved specifically for unresectable or metastatic liposarcoma, the company said. 

October 23, 2015

A Walgreens Specialy Pharmacy executive is taking on a role with the Leukemia & Lymphoma Society’s “Light the Night” fundraising walks. 

October 22, 2015

Merrimack Pharmaceuticals’ new pancreatic cancer drug was approved by the FDA Thursday. 

October 20, 2015

The PADSP has also launched a website,, that explains the REMS program to patients and lists medication that are currently marketed with a REMS.

October 16, 2015

No area of pharmacy is growing faster than specialty drugs.

October 16, 2015

The company, which has 266 employees and has a 40,000-sq. ft. prescription and order intake department in addition to a laboratory and pharmacy dispensary, was honored for its growth in the past few years. 

October 12, 2015

Colorectal cancer is the third most common type of cancer and is the second leading cause of cancer-related deaths in the U.S. 

October 9, 2015

The distinction recognizes CVS/specialty's commitment to helping people with arthritis and joint pain, and builds on the longstanding relationship between the two organizations. CVS/pharmacy is currently the exclusive retail drug store partner of the Arthritis Foundation.